SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-012807
Filing Date
2017-06-21
Accepted
2017-06-21 16:57:08
Documents
111
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 20-F taro-20f_20170331.htm 20-F 5918142
2 EX-12.1 taro-ex121_6.htm EX-12.1 16994
3 EX-12.2 taro-ex122_8.htm EX-12.2 17029
4 EX-13 taro-ex13_7.htm EX-13 11096
  Complete submission text file 0001564590-17-012807.txt   17766904

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT taro-20170331.xml EX-101.INS 4176956
6 XBRL TAXONOMY EXTENSION SCHEMA taro-20170331.xsd EX-101.SCH 100293
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE taro-20170331_cal.xml EX-101.CAL 112383
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE taro-20170331_def.xml EX-101.DEF 261050
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE taro-20170331_lab.xml EX-101.LAB 664216
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE taro-20170331_pre.xml EX-101.PRE 517005
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35463 | Film No.: 17923338
SIC: 2834 Pharmaceutical Preparations